TRANSMIT ENT (01326) Announces Delay in 2024/2025 Annual Results Publication, Trading Suspended from October 2

Stock News
Oct 02, 2025

TRANSMIT ENT (01326) announced that the company is still in the process of collecting and organizing required materials and documents from Wenlan to meet the needs for preparing consolidated financial statements and supporting auditor procedures. As a result, the company requires additional time to compile its 2024/2025 annual results.

Consequently, the publication of the 2024/2025 annual results and the dispatch of the 2024/2025 annual report will be delayed. The company has requested that trading in its shares be suspended on the Stock Exchange starting from 9:00 AM on Thursday, October 2, 2025, pending the publication of the 2024/2025 annual results announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10